## One-Line Verdict

Vertigo relief app should be tested as a narrow first-win workflow for Adults (skewing female and older) suffering recurrent positional vertigo/BPPV, plus ENT clinics, audiologists, and vestibular physiotherapists who could recommend or white-label the app for between-visit home care.. This is not a green light to build the full product. It is a structured prompt to test the buyer, the workflow, and the willingness to pay before committing engineering time.

## Problem

BPPV is the most common vestibular disorder, yet sufferers face long waits for ENT/vestibular specialists and struggle to perform repositioning maneuvers like the Epley correctly at home from static diagrams. Without guided head-positioning, episode tracking, and recurrence coaching, patients self-treat incorrectly, relapse (recurrence occurs in roughly half of cases), and miss daily activities. The painful part is not merely information overload; it is the repeated translation from raw activity into an artifact someone can trust and act on. The first product should therefore focus on the artifact, not on becoming a broad research platform.

The initial hypothesis is that Adults (skewing female and older) suffering recurrent positional vertigo/BPPV, plus ENT clinics, audiologists, and vestibular physiotherapists who could recommend or white-label the app for between-visit home care. already has enough recurring friction to justify a narrow tool if it saves time, reduces risk, or improves communication in a visible way.

## Who Pays

Adults (skewing female and older) suffering recurrent positional vertigo/BPPV, plus ENT clinics, audiologists, and vestibular physiotherapists who could recommend or white-label the app for between-visit home care. is the target buyer. The strongest early customer is the person who owns the consequence when this workflow is late, unclear, or inconsistent. They might pay when the product turns a recurring manual task into a dependable output with source links and a review path.

## Evidence Signals

- BPPV is the most frequent vestibular disorder, with cumulative lifetime prevalence reported between 2.4% and 10%, higher in women (about 3.2% vs 1.6% in men) and rising with age, per population-based epidemiology studies indexed on NIH/PMC.
- Canalith repositioning maneuvers (Epley, Semont) are level-1 evidence for posterior-canal BPPV; one prospective study reported a 63.6% success rate after one week of the Epley maneuver, rising to 72.7% after two weeks.
- BPPV follows a recurrent course in roughly 50% of cases, and in 86% of affected individuals it led to medical consultation, interruption of daily activities, or sick leave, underscoring high unmet demand for reliable home management.
- The global digital vestibular rehabilitation platforms market reached about USD 498.2M in 2024 and is forecast to grow at a ~13.5% CAGR to roughly USD 1.56B by 2033, with homecare an emerging fast-growing end-user segment.

These signals are directional, not proof. The report should move to build only after live buyer conversations confirm that the workflow repeats and that the buyer can describe a concrete cost.



## Scorecard

- **Opportunity: 6/10 (Promising)** - Vertigo relief app has an editorial confidence score of 58/100 before live buyer validation.
- **Problem: 5/10 (Promising)** - BPPV is the most common vestibular disorder, yet sufferers face long waits for ENT/vestibular specialists and struggle to perform repositioning maneuvers like the Epley correctly at home from static diagrams. Without guided head-positioning, episode tracking, and recurrence coaching, patients self-treat incorrectly, relapse (recurrence occurs in roughly half of cases), and miss daily activities.
- **Feasibility: 6/10 (Promising)** - A moderate build can work if the MVP stays limited to the first repeated workflow.
- **Why now: 10/10 (Exceptional)** - COVID accelerated a durable shift to telehealth and home-based rehab, smartphones now carry accurate motion/gyroscope sensors capable of measuring head-tilt angles in real time, and reimbursement for digital therapeutics is maturing. The digital vestibular rehabilitation platforms market was estimated near USD 498M in 2024 with a projected ~13.5% CAGR through 2033, signaling growing buyer and payer acceptance.

## Validation Score

**56/100 - Research.** Research is the current validation verdict: problem severity is the strongest signal, while competitive saturation is the main evidence gap to close before scaling the build.

Rubric version: INAV-VALIDATION-2026-06-04

- **Demand signal: 6/10, weight 24%.** Demand looks thin because the report has 4 source-backed signal(s), an editorial confidence of 58/100, and a defined buyer in Consumer digital health for vestibular disorders, specifically BPPV and dizziness self-management, within the broader telerehabilitation and digital therapeutics space..
- **Problem severity: 6.3/10, weight 22%.** Problem severity is thin when the buyer pain, customer value, and dream-outcome scores are combined.
- **Willingness to pay: 5.5/10, weight 20%.** Willingness to pay is weak; the model has a monetization hypothesis, but it must still be proven through paid pilots or explicit pricing objections.
- **Competitive saturation: 3.9/10, weight 18%.** Competitive room is reduced by 3 recorded alternative(s); the wedge must stay narrow and differentiated.
- **Feasibility: 6.2/10, weight 16%.** Feasibility is thin for a moderate build if the MVP is limited to the first measurable workflow.

Next validation step: Build a lightweight landing page plus a no-code guided-Epley walkthrough and run targeted ads to vertigo/BPPV search terms; measure email signups and the share who complete the maneuver flow. Validate B2B demand by pitching 10-15 ENT/audiology/physio clinics on recommending it for between-visit home care and counting how many agree to trial it with patients.

## Business Fit

- **Revenue potential:** $250K-$2M ARR potential if the wedge proves budget urgency and becomes a recurring workflow.
- **Execution difficulty:** Execution is moderate; the main constraint is staying narrow enough for a first proof loop.
- **Go-to-market:** Start with manual concierge output, direct outreach, and community proof before paid acquisition.
- **Founder fit:** Best for an AI-assisted solo founder who can interview the buyer and ship a focused first version quickly.

## Offer Ladder

- **Lead magnet:** Vertigo Relief App checklist (Free) - Helps Adults (skewing female and older) suffering recurrent positional vertigo/BPPV, plus ENT clinics, audiologists, and vestibular physiotherapists who could recommend or white-label the app for between-visit home care. audit the painful workflow before buying software. Goal: Capture qualified leads and learn the buyer's exact language.
- **Frontend offer:** Concierge review or paid template ($19-$99) - Delivers the first useful output manually before automation is trusted. Goal: Validate urgency, workflow fit, and willingness to pay.
- **Core offer:** Vertigo relief app focused SaaS ($49-$499/month) - Turns the recurring manual workflow into a repeatable product loop. Goal: Create the recurring revenue product after the narrow wedge survives tests.
- **Continuity:** Monitoring, benchmarks, and monthly reporting ($99-$1,000/year add-on) - Keeps the buyer engaged with ongoing proof, saved time, or reduced risk. Goal: Increase retention and make the product part of a routine.
- **Backend offer:** Done-with-you setup, agency, or team rollout (Custom) - Adds implementation help, integrations, and workflow migration. Goal: Capture higher-value accounts once the productized wedge is proven.

## Economics

Derived from this report's "Core offer" offer-ladder stage ($49-$499/month). These are price-anchored scenarios, not market-size claims.

- **Proof (10 customers):** $490-$4,990 MRR. Ten paying customers proves willingness to pay and funds continued validation.
- **Wedge (50 customers):** $2,450-$24,950 MRR. Fifty customers in one niche makes the workflow the default in that circle and feeds referrals.
- **Vertical leader (250 customers):** $12,250-$124,750 MRR. A few hundred accounts in one vertical is a real business before any horizontal expansion.

- **Break-even:** At $49-$499/month, 1 customers cover the stated Local-first MVP budget: $0-$10K before paid acquisition. budget within a month; fewer if they land at the top of the range.
- **Sizing:** Size the buyer universe in one day: count adults (skewing female and older) suffering recurrent positional vertigo/bppv, plus ent clinics, audiologists, and vestibular physiotherapists who could recommend or white-label the app for between-visit home care. reachable through the report's channels (directories, associations, communities) until the list stops growing — the test only needs the first 100 names, not a TAM estimate.
- **Benchmark:** 3 adjacent products recorded (2 strong). Position the price against what adults (skewing female and older) suffering recurrent positional vertigo/bppv, plus ent clinics, audiologists, and vestibular physiotherapists who could recommend or white-label the app for between-visit home care. already pays in time or tooling, and verify each named alternative's public pricing during the sprint.

## Why Now

- **Demand visibility: 5/10** - BPPV is the most frequent vestibular disorder, with cumulative lifetime prevalence reported between 2.4% and 10%, higher in women (about 3.2% vs 1.6% in men) and rising with age, per population-based epidemiology studies indexed on NIH/PMC. Build only if the complaint repeats across interviews, posts, or existing workflow artifacts.
- **Tooling readiness: 6/10** - AI-assisted product work and managed infrastructure reduce the first-version cost. The first release should automate one high-friction step rather than become a broad platform.
- **Budget clarity: 4/10** - Freemium consumer subscription (core maneuver guides free; advanced tracking, history export, and reminders behind a monthly/annual plan) plus a B2B clinic tier where ENT/audiology/physio practices license the app for patient home programs. Ask for money during validation before building the full workflow.
- **Competitive window: 8/10** - The wedge is specific enough to test without claiming the whole market. Position around one buyer and one measurable first-win outcome.

## Proof Signals

- **Pain: 5/10 - Repeated workflow friction.** BPPV is the most frequent vestibular disorder, with cumulative lifetime prevalence reported between 2.4% and 10%, higher in women (about 3.2% vs 1.6% in men) and rising with age, per population-based epidemiology studies indexed on NIH/PMC.
- **Money: 4/10 - Budget hypothesis.** Adults (skewing female and older) suffering recurrent positional vertigo/BPPV, plus ENT clinics, audiologists, and vestibular physiotherapists who could recommend or white-label the app for between-visit home care. is the first group to test because the monetization path is: Freemium consumer subscription (core maneuver guides free; advanced tracking, history export, and reminders behind a monthly/annual plan) plus a B2B clinic tier where ENT/audiology/physio practices license the app for patient home programs.
- **Urgency: 6/10 - Switching pressure.** Urgency becomes real only if the current workaround costs time, risk, money, or reputation every week.
- **Distribution: 10/10 - Reachable buyer language.** The first channel should be whichever source lane already contains the buyer's vocabulary.

## Existing Product Check

- **strong:** [Vertigo BPPV Vestibular Coach](https://apps.apple.com/us/app/vertigo-bppv-vestibular-coach/id6764793454) - Directly overlapping product: a toolkit to manage BPPV, track dizziness episodes, and follow guided Epley and Brandt-Daroff exercises, including a 30-second motion-sensor balance self-check. Demonstrates the exact MVP exists and validates demand while raising the differentiation bar.
- **strong:** [Epley Assist: Dizziness Relief](https://apps.apple.com/us/app/epley-assist-dizziness-relief/id6448395635) - A free, well-rated (4.9 stars) iOS app from IntuitiveMed that guides users through the Epley maneuver with animated visuals and a candidacy survey. Confirms a free competitor already covers core guided-maneuver functionality, pressuring monetization and feature differentiation.
- **possible:** [DizzyFIX Vertigo & BPPV Relief](https://www.dizzyfix.com/) - A physical/clinical BPPV repositioning aid with associated app guidance, literature-based and adopted by some clinicians, indicating an established player straddling consumer and professional channels that a clinic-focused B2B tier would compete against.

## Market Gaps

### Underserved Segments

- Adults (skewing female and older) suffering recurrent positional vertigo/BPPV, plus ENT clinics, audiologists, and vestibular physiotherapists who could recommend or white-label the app for between-visit home care. who still run the workflow in spreadsheets, generic docs, email, or chat threads.
- Small teams in Consumer digital health for vestibular disorders, specifically BPPV and dizziness self-management, within the broader telerehabilitation and digital therapeutics space. that feel the pain weekly but are too narrow for broad incumbents.
- New adopters who need guided proof before committing to a larger platform.

### Feature Gaps

- A narrow workflow that reaches value without configuration-heavy onboarding.
- A buyer-facing proof artifact that shows time saved, risk reduced, or communication improved.
- A handoff path from manual concierge service to repeatable software.

### Differentiation Levers

- Use specificity as the wedge: one buyer, one workflow, one measurable result.
- Show proof earlier than broad competitors with before-and-after examples and small pilot data.
- Keep implementation lighter than incumbent suites or generic AI assistants.

## Execution Plan

- **Business type:** Consumer app product
- **Timeline:** 4-8 weeks
- **Budget:** Local-first MVP budget: $0-$10K before paid acquisition.
- **MVP approach:** Build only the first-win workflow for "Vertigo relief app" and keep research, setup, and exceptions manual until the wedge is proven.
- **Initial offer:** Concierge review or paid template

### Acquisition Channels

- **Community pain posts:** Problem teardown, interview ask, and short demo clip. Cadence: Weekly. Metric: 5 qualified calls or 10 detailed replies in 7 days
- **Direct outreach:** Concierge pilot offer with a manually prepared sample. Cadence: Daily during validation. Metric: 3 paid pilots, LOIs, or budget-owner follow-ups
- **Searchable comparison content:** Before-and-after page or alternatives memo for the exact workflow. Cadence: Bi-weekly. Metric: Organic clicks, booked demos, or waitlist joins from comparison intent
- **Launch directory:** Single-purpose demo and first-win story. Cadence: Once MVP is clickable. Metric: 25% demo completion or 10 waitlist joins

### Milestones

1. Interview 10 people who match the buyer persona.
2. Ship a clickable demo or concierge workflow that produces the first useful artifact.
3. Run one paid pilot or collect explicit pricing objections before automating the rest.
4. Promote to a deeper build plan only after the wedge survives validation.

### Success Metrics

- Problem resonance: 5+ calls or 10+ detailed replies.
- Activation: 25% of demo visitors complete the first-win path.
- Commercial pull: 3 paid pilots, LOIs, or concrete procurement next steps.

## Framework Fit

- **Value equation:** dream outcome 8/10, perceived likelihood 6/10, time delay 6/10, effort and sacrifice 7/10.
- **Market matrix:** Category king candidate. High value plus high uniqueness deserves deeper research; lower uniqueness requires a clear distribution advantage.
- **Audience-community-product:** audience 5/10, community 9/10, product 6/10.
- **Category:** Consumer app product for Adults (skewing female and older) suffering recurrent positional vertigo/BPPV, plus ENT clinics, audiologists, and vestibular physiotherapists who could recommend or white-label the app for between-visit home care.; likely alternative is Vertigo BPPV Vestibular Coach.

## Community Signals

- **Reddit / forums:** Research lane. Look for complaints, workarounds, and repeated questions. First move: Post a problem teardown for Consumer digital health for vestibular disorders, specifically BPPV and dizziness self-management, within the broader telerehabilitation and digital therapeutics space. and ask how people solve it today.
- **Launch communities:** Validation lane. Launch traction shows whether the promise is legible. First move: Ship a narrow demo and watch which promise gets clicks.
- **Review and alternative pages:** Objection lane. Pricing and alternatives expose buyer objections. First move: Write an alternatives page that owns one narrow use case.

## Keyword Intelligence

Keyword signals should be treated as directional. The strongest terms combine Consumer digital health for vestibular disorders, specifically BPPV and dizziness self-management, within the broader telerehabilitation and digital therapeutics space., the buyer workflow, and the first output the product creates.

- **vertigo workflow:** directional medium; rising with AI adoption; medium competition
- **relief validation:** directional low; steady niche demand; low competition

## MVP Scope

### MVP

An iOS/Android app that (1) screens BPPV candidacy with a short safety survey and optional motion-sensor self-check, (2) walks users through the Epley and Brandt-Daroff maneuvers with animated step-by-step cues plus audio guidance and gyroscope-based head-angle feedback, and (3) logs dizziness episodes, triggers, and symptom severity over time. Ship with a strong 'not a substitute for medical advice' disclaimer and a prompt to see a clinician when red-flag symptoms appear.

The first version should produce one trusted output, preserve source links, and make human review explicit. Everything else can stay manual: onboarding, unusual edge cases, integrations, templates, and account management.

## Risks

- Regulatory and medical-claims risk: positioning the app as treating or curing BPPV can trigger FDA software-as-a-medical-device scrutiny and liability; marketing must stay within wellness/educational claims and carry medical disclaimers.
- Clinical safety risk: the Epley maneuver is unsafe for some users (neck/back disease, vascular conditions, retinal detachment) and self-diagnosis may miss serious causes of vertigo such as stroke, so robust screening and escalation prompts are essential.
- Crowded niche with several established free and low-cost competitors and inherently low willingness-to-pay for an episodic, often self-resolving condition, making retention and recurring revenue difficult.
- Trying to build a broad platform before the narrow workflow has proof.

## Validation Experiments

### First Validation Test

Build a lightweight landing page plus a no-code guided-Epley walkthrough and run targeted ads to vertigo/BPPV search terms; measure email signups and the share who complete the maneuver flow. Validate B2B demand by pitching 10-15 ENT/audiology/physio clinics on recommending it for between-visit home care and counting how many agree to trial it with patients.

### Additional Tests

- Write the one-sentence promise and test it in the strongest channel.
- Create the lead magnet and use it to recruit interviews.
- Build the smallest demo that proves the first win.

## Kill Criteria

- Fewer than five qualified buyers agree to discuss the workflow after targeted outreach.
- No buyer can name a current cost in time, money, risk, or reputation.
- The first demo does not produce a clear next step, paid pilot, or specific objection.

## Founder Fit

Score: 8/10. A solo or AI-assisted founder with direct access to Adults (skewing female and older) suffering recurrent positional vertigo/BPPV, plus ENT clinics, audiologists, and vestibular physiotherapists who could recommend or white-label the app for between-visit home care..

### Advantages

- Can talk to the buyer before writing much code.
- Can ship a narrow first-win demo quickly.
- Can use local-first research artifacts to keep validation moving without a large team.

### Gaps

- Needs real buyer access, not only desk research.
- Needs proof of budget or repeated urgency.
- Needs a crisp wedge before broad product work starts.

### Avoid If

- You cannot reach the buyer directly.
- The idea only sounds interesting but does not save time, money, risk, or reputation.
- You want to build the full platform before validating the first workflow.

## Roast

Promising enough to test, not strong enough to build broadly.

### Blind Spots

- Regulatory and medical-claims risk: positioning the app as treating or curing BPPV can trigger FDA software-as-a-medical-device scrutiny and liability; marketing must stay within wellness/educational claims and carry medical disclaimers.
- A broad AI assistant can flatten differentiation unless the wedge is painfully specific.
- The first release can become a generic dashboard if the job is not named tightly.

### Hard Questions

- Who wakes up already trying to solve this?
- What do they stop paying for or stop doing when this works?
- What proof would make a skeptical buyer trust it in one screen?
- What is the smallest paid version of this idea?

### De-Risking Moves

- Sell a manual pilot before building automation.
- Record five exact phrases buyers use to describe the pain.
- Cut any feature that does not support the first measurable win.

## Build Handoff

### Build Prompt

Build a narrow MVP for "Vertigo relief app" for Adults (skewing female and older) suffering recurrent positional vertigo/BPPV, plus ENT clinics, audiologists, and vestibular physiotherapists who could recommend or white-label the app for between-visit home care.. Preserve the evidence, build only the first-win workflow, include source links, and treat Build a lightweight landing page plus a no-code guided-Epley walkthrough and run targeted ads to vertigo/BPPV search terms; measure email signups and the share who complete the maneuver flow. Validate B2B demand by pitching 10-15 ENT/audiology/physio clinics on recommending it for between-visit home care and counting how many agree to trial it with patients. as the first acceptance gate.

### Review Prompt

Review the "Vertigo relief app" MVP for over-breadth, unsupported claims, weak buyer proof, privacy risk, and missing validation instrumentation. Do not approve expansion until the kill criteria and success metrics are measurable.

### Build Actions

- Delete any report section that feels generic before building.
- Run the lead magnet and first-win demo tests.
- Promote to deeper implementation only once the wedge survives interviews or paid-pilot outreach.

## Sources

- [Epidemiology of benign paroxysmal positional vertigo: a population based study](https://pmc.ncbi.nlm.nih.gov/articles/PMC2117684/) - Population-based epidemiology of BPPV reporting lifetime prevalence around 2.4%, with higher rates in women and the elderly, and noting that the condition led most sufferers to seek medical care or interrupt daily activities. Establishes the size and demographics of the target buyer.
- [Efficacy of Epley's Maneuver in Treating BPPV Patients: A Prospective Observational Study](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4606415/) - Prospective study documenting Epley maneuver success rates of roughly 63.6% at one week rising to 72.7% at two weeks, supporting the clinical rationale that a well-guided home Epley protocol can deliver measurable symptom relief for posterior-canal BPPV.
- [Home Epley Maneuver](https://www.hopkinsmedicine.org/health/treatment-tests-and-therapies/home-epley-maneuver) - Johns Hopkins Medicine patient guide explaining how to perform the Epley maneuver at home, its mechanism, who should avoid it (neck/back/vascular/retinal conditions), and that BPPV often recurs. Confirms the app concept maps to a recognized, clinician-endorsed home procedure.
- [Digital Vestibular Rehabilitation Platforms Market Research Report 2033](https://growthmarketreports.com/report/digital-vestibular-rehabilitation-platforms-market) - Market report estimating the digital vestibular rehabilitation platforms market near USD 498M in 2024 with a ~13.5% CAGR to about USD 1.56B by 2033, North America leading and homecare a fast-growing segment, supporting the whyNow timing and commercial opportunity.

---

# Derived deliverables (computed from this report's own data)

Vertical: [Healthcare & Life Sciences](https://ideanavigatorai.com/verticals/healthcare/) · Full report: https://ideanavigatorai.com/ideas/vertigo-relief-app/

## Economics (price-anchored scenarios)

Derived from this report's "Core offer" offer-ladder stage ($49-$499/month). These are price-anchored scenarios, not market-size claims.

- **Proof (10 customers):** $490-$4,990 MRR. Ten paying customers proves willingness to pay and funds continued validation.
- **Wedge (50 customers):** $2,450-$24,950 MRR. Fifty customers in one niche makes the workflow the default in that circle and feeds referrals.
- **Vertical leader (250 customers):** $12,250-$124,750 MRR. A few hundred accounts in one vertical is a real business before any horizontal expansion.
- **Break-even:** At $49-$499/month, 1 customers cover the stated Local-first MVP budget: $0-$10K before paid acquisition. budget within a month; fewer if they land at the top of the range.
- **Sizing:** Size the buyer universe in one day: count adults (skewing female and older) suffering recurrent positional vertigo/bppv, plus ent clinics, audiologists, and vestibular physiotherapists who could recommend or white-label the app for between-visit home care. reachable through the report's channels (directories, associations, communities) until the list stops growing — the test only needs the first 100 names, not a TAM estimate.
- **Benchmark:** 3 adjacent products recorded (2 strong). Position the price against what adults (skewing female and older) suffering recurrent positional vertigo/bppv, plus ent clinics, audiologists, and vestibular physiotherapists who could recommend or white-label the app for between-visit home care. already pays in time or tooling, and verify each named alternative's public pricing during the sprint.

## 7-day validation sprint

- **Day 1 — Build the buyer list.** List 50-100 named adults (skewing female and older) suffering recurrent positional vertigo/bppv, plus ent clinics, audiologists, and vestibular physiotherapists who could recommend or white-label the app for between-visit home care. prospects from Community pain posts and Direct outreach — names, not categories. _Threshold: 50+ named, reachable buyers on the list._
- **Day 2 — Join the watering holes.** Join and observe Reddit / forums, Launch communities, Review and alternative pages. Collect the exact words buyers use for this pain. _Threshold: 10+ verbatim pain quotes captured._
- **Day 3 — Send first outreach.** Send the cold outreach template (below) to 15 buyers from the day-1 list, personalized with one detail each. _Threshold: 15 sent; 3+ replies of any kind._
- **Day 4 — Run buyer interviews.** Hold 15-minute calls using the interview script (below). Listen for current workarounds and what they cost. _Threshold: 3+ completed interviews._
- **Day 5 — Run the report's validation test.** Build a lightweight landing page plus a no-code guided-Epley walkthrough and run targeted ads to vertigo/BPPV search terms; measure email signups and the share... _Threshold: Problem resonance: 5+ calls or 10+ detailed replies._
- **Day 6 — Make the smoke offer.** Offer "Concierge review or paid template" at $19-$99 to every interviewed buyer. Manual delivery is fine — payment is the signal. _Threshold: 1+ pre-commitment (payment, signed LOI, or scheduled paid pilot)._
- **Day 7 — Decide against the kill criteria.** Score the week against this report's kill criteria, then take the stated next validation step: Build a lightweight landing page plus a no-code guided-Epley walkthrough and run targeted ads to vertigo/BPPV search terms; measure email signups and the share... _Threshold: A written build / keep-testing / kill decision._
- Pass: thresholds on days 3, 4, and 6 are met — proceed to the next validation step with real buyer language in hand.
- Kill or rethink if the week confirms: Fewer than five qualified buyers agree to discuss the workflow after targeted outreach.

## First-contact kit

Subject lines: Question about vertigo workflow · How are you handling bppv is the most common vestibular disorder, yet sufferers... · 15 minutes on a consumer digital health for vestibular disorders, specifically bppv and dizziness self-management, within the broader telerehabilitation and digital therapeutics space. workflow?

```
Hi {{firstName}},

I'm researching how adults (skewing female and older) suffering recurrent positional vertigo/bppv, plus ent clinics, audiologists, and vestibular physiotherapists who could recommend or white-label the app for between-visit home care. handle this today: BPPV is the most common vestibular disorder, yet sufferers face long waits for ENT/vestibular specialists and struggle to perform repositio...

I'm not selling anything yet — I'm testing whether "Vertigo relief app" is worth building, and I'd rather learn from people living the workflow than guess.

Would you trade 15 minutes for first access (and a say in what gets built) if it goes ahead?

{{yourName}}
```

Interview script:
1. Walk me through the last time this happened: BPPV is the most common vestibular disorder, yet sufferers face long waits for ENT/vestibular specialists and struggle... What did you actually do?
2. What does that workaround cost you — in hours, money, or risk — in a normal month?
3. What have you already tried or bought to fix it, and why didn't it stick?
4. If "An iOS/Android app that (1) screens BPPV candidacy with a short safety survey and optional motion-s..." existed, what would have to be true for you to switch in the first week?
5. Who else feels this worse than you do — and would you introduce me?

Where to send it:
- Community pain posts — Problem teardown, interview ask, and short demo clip
- Direct outreach — Concierge pilot offer with a manually prepared sample
- Searchable comparison content — Before-and-after page or alternatives memo for the exact workflow
- Reddit / forums — Post a problem teardown for Consumer digital health for vestibular disorders, specifically BPPV and dizziness self-management, within the broader telerehabilitation and digital therapeutics space. and ask how people solve it today.
- Launch communities — Ship a narrow demo and watch which promise gets clicks.

## Pivot map

### Same problem, different buyer: Budget owner who feels the operational cost of the broken workflow.

The workflow pain in this report is not exclusive to adults (skewing female and older) suffering recurrent positional vertigo/bppv, plus ent clinics, audiologists, and vestibular physiotherapists who could recommend or white-label the app for between-visit home care.. Budget owner who feels the operational cost of the broken workflow. faces the same friction with their own budget and urgency.

First test: Re-run day 3 of the sprint (15 outreach messages) against this buyer only, and compare reply rates before changing anything else.

### Same workflow, adjacent vertical: Agencies & Professional Services

This report's language already overlaps Agencies & Professional Services (marketing agencies). The same first-win workflow usually transfers with new vocabulary and one changed integration.

First test: Rewrite the one-line promise for a Agencies buyer and test it in that vertical's channels before building anything new.

### Same wedge, alternate model: a productized service (fixed-price, done-for-you delivery)

This report monetizes via "Freemium consumer subscription (core maneuver guides free; advanced tracking, history export, and reminders behind a monthly/annual plan) plus a B2B clinic tier where ENT/audiology/physio practices license the app for patient home programs.". Concierge delivery validates willingness to pay before any software exists and earns the workflow knowledge the product needs.

First test: Offer both versions on day 6 of the sprint and let the first pre-commitment choose the model.